Katz J L, Witkin J M
Psychobiology Laboratory, NIDA Addiction Research Center, Baltimore, MD 21224.
Psychopharmacology (Berl). 1992;109(1-2):241-4. doi: 10.1007/BF02245508.
The effects of the dopamine receptor D1 partial agonist, SKF 38393, on behavior maintained by cocaine was assessed in squirrel monkeys (Saimiri sciureus). One group of subjects was trained to press a key under a fixed-ratio 30-response schedule of cocaine injection; when green stimulus lamps were illuminated each 30th response produced an injection (17 micrograms/kg) followed by a 1-min period during which the lights were out and responses had no scheduled consequences. Another group of squirrel monkeys was trained under an identical schedule with food reinforcement. SKF 38393 produced dose-related decreases in rates of responding maintained by either cocaine injection or food presentation. Rates of responding maintained by cocaine were decreased to a greater extent than those maintained by food. The ED50 value for SKF 38393 for responding maintained by cocaine was 2.53 mg/kg (95% CL: 1.22-5.23), whereas that value was 15.63 mg/kg (95% CL: 2.83-86.33) for responding maintained by food. Rates of responding maintained by cocaine were an inverted-U-shaped function of dose. Pretreatment with 3.0 mg/kg SKF 38393 shifted the ascending limb of the cocaine dose-effect curve to the right. These findings suggest that indirect D1-receptor activation plays a role in the reinforcing effects of cocaine, and that drugs acting at D1 receptors may show promise as therapeutic agents in the treatment of cocaine abuse.
在松鼠猴(Saimiri sciureus)中评估了多巴胺受体D1部分激动剂SKF 38393对由可卡因维持的行为的影响。一组受试者被训练在固定比率30次反应的可卡因注射时间表下按键;当绿色刺激灯亮起时,每第30次反应会产生一次注射(17微克/千克),随后是1分钟的熄灯期,在此期间反应没有预定的后果。另一组松鼠猴在相同的时间表下接受食物强化训练。SKF 38393使由可卡因注射或食物呈现维持的反应率产生剂量相关的降低。由可卡因维持的反应率比由食物维持的反应率降低的程度更大。SKF 38393对由可卡因维持的反应的ED50值为2.53毫克/千克(95%置信区间:1.22 - 5.23),而对由食物维持的反应,该值为15.63毫克/千克(95%置信区间:2.83 - 86.33)。由可卡因维持的反应率是剂量的倒U形函数。用3.0毫克/千克SKF 38393预处理使可卡因剂量 - 效应曲线的上升支向右移动。这些发现表明间接D1受体激活在可卡因的强化作用中起作用,并且作用于D1受体的药物可能有望作为治疗可卡因滥用的治疗剂。